Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C13orf16 Inhibitors

C13orf16 Inhibitors is a class of compounds specifically designed to modulate the function or activity of the protein encoded by the C13orf16 gene, also known as TEX29. This protein is believed to have roles in specific cellular processes, and the inhibition of its function could provide insights into its biological significance and the broader cellular pathways in which it participates.

The mechanism by which C13orf16 Inhibitors function is dependent on the molecular nature and structure of the protein itself. For proteins with enzymatic activity, inhibitors typically bind to the active site, preventing the substrate from interacting and thus halting the enzyme's action. However, for proteins that act as scaffolds or interaction partners for other proteins, inhibitors might function by preventing these protein-protein interactions. Such a mechanism might involve the inhibitor binding to an allosteric site, a region on the protein separate from its main functional site, causing a conformational change that makes interaction with its regular partners impossible. In some cases, inhibitors can also bind covalently to the target protein, leading to irreversible inhibition. The design and specificity of C13orf16 Inhibitors would largely hinge on the specific structural and functional attributes of the C13orf16 protein. Through careful molecular design and biochemical testing, researchers can tailor these inhibitors to achieve optimal binding affinity and specificity, ensuring minimal off-target effects.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Binds to the active site of certain kinases, preventing interaction with natural ligands.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Allosteric inhibitor that binds mTOR, inducing a conformational change and altering its function.

α-Iodoacetamide

144-48-9sc-203320
25 g
$255.00
1
(1)

Binds covalently to cysteine residues in proteins, potentially rendering them inactive.

Trifluoperazine Dihydrochloride

440-17-5sc-201498
sc-201498A
1 g
5 g
$57.00
$101.00
9
(1)

Targets a regulatory domain (Calmodulin), inhibiting its activation or interaction with partner proteins.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibits the activity of protein phosphatases, which could affect post-translational modifications.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Blocks the binding pocket of some proteins, preventing them from interacting with cellular partners.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Forms a stable complex with RNA polymerase II, preventing its transcriptional activity.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Interacts with the transport protein complex and prevents protein dimerization in the Golgi apparatus.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Induces degradation of proteins through the ubiquitin-proteasome pathway.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Interferes with the folding of newly synthesized proteins, leading to their misfolding and loss of function (specifically N-linked glycosylation).